MedTrace Logo

Blood Loss Measurement During Cesarean Delivery

NCT02667600 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 61

Last updated 2018-09-05

No results posted yet for this study

Summary

The aim of this study is to assess the ability of the Triton Device to measure blood loss among women undergoing elective and non-elective cesarean delivery. This patient population often experiences significant blood loss during surgery, and measurements of surgical blood loss are often inaccurate.

Conditions

  • Pregnancy

Sponsors & Collaborators

  • Alex James Butwick

    lead OTHER

Principal Investigators

  • Alexander J Butwick, FRCA · Stanford University

  • Brendan Carvalho, MBBCh, FRCA · Stanford University

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2017-08-31
Completion
2017-12-12

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02667600 on ClinicalTrials.gov